Why Does Every Hepatocellular Carcinoma Clinical Trial Using Molecular Targeted Agents Fail?

Title
Why Does Every Hepatocellular Carcinoma Clinical Trial Using Molecular Targeted Agents Fail?
Authors
Keywords
-
Journal
Liver Cancer
Volume 1, Issue 2, Pages 59-60
Publisher
S. Karger AG
Online
2012-10-01
DOI
10.1159/000342401

Ask authors/readers for more resources

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started